• DOI:10.1371/journal.pntd.0005735
Corpus ID: 30241217

Mass drug administration for the prevention human strongyloidiasis should consider concomitant treatment of dogs

@article{Beknazarova2017MassDA,
  title={Mass drug administration for the prevention human strongyloidiasis should consider concomitant treatment of dogs},
  author={Meruyert Beknazarova and H. Whiley and K. Ross},
  journal={PLoS Neglected Tropical Diseases},
  year={2017},
  volume={11}
}

Meruyert Beknazarova, H. Whiley, K. Ross

Published 2017

Biology, Medicine

PLoS Neglected Tropical Diseases

Strongyloides stercoralis is the causative agent of strongyloidiasis, which affects more than 300 million people worldwide [1]. Canine strongyloidiasis is also caused by the same species, S. stercoralis of an animal origin with up to 50% worldwide prevalence [2–5]. It is known that human S. stercoralis strains can infect dogs in laboratory settings (dogs have to be immunosuppressed to maintain infection) [6–8]. Increasing evidence suggests that S. stercoralis could be a potential zoonotic… CONTINUE READING

View PDF

Save to Library

Create Alert

Cite

Launch Research Feed